Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 20;16(8):368.
doi: 10.3390/toxins16080368.

Bacterial Porins and Their Procoagulant Role: Implication in the Pathophysiology of Several Thrombotic Complications during Sepsis

Affiliations
Review

Bacterial Porins and Their Procoagulant Role: Implication in the Pathophysiology of Several Thrombotic Complications during Sepsis

Carmine Siniscalchi et al. Toxins (Basel). .

Abstract

The association between sepsis and thrombotic complications is still not well known. Different mechanisms have been shown to be involved in the sepsis-induced prothrombotic state, but clinical scenarios may differ. In this review, we have summarized the role that bacterial products such as porins and toxins can have in the induction of the prothrombotic state during sepsis and the interaction that they can have with each other. Furthermore, the above-mentioned mechanisms might be involved in the pattern of the clinical presentation of thrombotic events during bacterial sepsis, which would secondarily explain the association between sepsis and venous thromboembolism, the association between sepsis and disseminated intravascular coagulation, and the association between sepsis and microangiopathic venous thromboembolism.

Keywords: bacteria; porins; sepsis; thromboembolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Bacterial infection and hypercoagulable state.

References

    1. Marston H.D., Dixon D.M., Knisely J.M., Palmore T.N., Fauci A.S. Antimicrobial resistance. JAMA. 2016;316:1193–1204. doi: 10.1001/jama.2016.11764. - DOI - PubMed
    1. Brown E.D., Wright G.D. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336–343. doi: 10.1038/nature17042. - DOI - PubMed
    1. Khakpour S., Wilhelmsen K., Hellman J. Vascular endothelial cell toll-like receptor pathways in sepsis. Innate Immun. 2015;21:827–846. doi: 10.1177/1753425915606525. - DOI - PubMed
    1. Chen F., Zou L., Williams B., Chao W. Targeting toll-like receptors in sepsis: From bench to clinical trials. Antioxid. Redox Signal. 2021;35:1324–1339. doi: 10.1089/ars.2021.0005. - DOI - PMC - PubMed
    1. Dahlbäck B. Blood coagulation. Lancet. 2000;335:1627–1632. doi: 10.1016/S0140-6736(00)02225-X. - DOI - PubMed

LinkOut - more resources